Bhopal C. Mohapatra

This study identifies Orai1 and EHD2 as essential for Ca2+-dependent plasma membrane repair and mechanoadaptation in response to mechanical injury and bacterial toxins.

This study identifies ECD as a novel androgen receptor target that promotes prostate cancer by enhancing glycolysis and oncogenic traits.

This study shows ECD and ERBB2 cooperate in breast cancer by enhancing unfolded protein response and glycolysis through direct mRNA binding and increased glucose uptake.